Live webinar for Canadian test developers

29 May 2019

Green leaf symbol with CIHR IRSC letters

Written by Ruth Neale, Project Manager, Longitude Prize

Could your AMR diagnostic win the Longitude Prize?

The Longitude Prize team is inviting Canadian institutes, researchers & companies that are working on point-of-care diagnostics tests to help tackle antibiotic resistance to join a live webinar, hosted and moderated by the Canadian Institutes for Health Research (CIHR).

Date: Tuesday 18 June (11am-12pm EDT)

●    Daniel Berman, Longitude Prize, Nesta Challenges, London
●    Peter Whitehead, Longitude Prize Competitor Light AI, Vancouver

In this webinar, Daniel Berman from Nesta will introduce the Longitude Prize, an international challenge prize competition that will ultimately select one point-of-care diagnostic test to receive a grand pay-out of £8 million. The winning point-of-care test will significantly reduce the unnecessary use of antibiotics and/or better steer the deployment of antibiotics. It must be be affordable, accurate and rapid. This test must be practical to use in the North America and Europe as well as in low and middle-income countries (LMICs).

Currently, 83 Longitude Prize teams are competing to fulfill eight criteria. Test developers at research centres and companies (SMEs or larger entities) can enter. The competition is still open to new registrants through 2022. The first team who can successfully meet the criteria will win an £8 million payout.

In the second part of this webinar Peter Whitehead, who heads up the company Light AI from Vancouver, will give his experience as a Longitude competitor. Light AI are currently developing tests that use multiple wavelengths of light, backed by advanced Artificial Intelligence, to determine the presence or absence of streptococcal throat infections. The Strepic devices will be rapid (results in less than a minute) handheld, affordable, minimally invasive, point-of-care and simple to use. By differentiating between viral and bacterial pharyngitis, Strepic has the potential to become an important device for patient management, and for the stewardship of antibiotic resources.

To register for the webinar, please click here. For more information, please contact

This webinar will be recorded and shared for everyone via a video after the webinar.